| UniProt ID | PARP2_HUMAN | |
|---|---|---|
| UniProt AC | Q9UGN5 | |
| Protein Name | Poly [ADP-ribose] polymerase 2 | |
| Gene Name | PARP2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 583 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Involved in the base excision repair (BER) pathway, by catalyzing the poly(ADP-ribosyl)ation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. [PubMed: 10364231] | |
| Protein Sequence | MAARRRRSTGGGRARALNESKRVNNGNTAPEDSSPAKKTRRCQRQESKKMPVAGGKANKDRTEDKQDGMPGRSWASKRVSESVKALLLKGKAPVDPECTAKVGKAHVYCEGNDVYDVMLNQTNLQFNNNKYYLIQLLEDDAQRNFSVWMRWGRVGKMGQHSLVACSGNLNKAKEIFQKKFLDKTKNNWEDREKFEKVPGKYDMLQMDYATNTQDEEETKKEESLKSPLKPESQLDLRVQELIKLICNVQAMEEMMMEMKYNTKKAPLGKLTVAQIKAGYQSLKKIEDCIRAGQHGRALMEACNEFYTRIPHDFGLRTPPLIRTQKELSEKIQLLEALGDIEIAIKLVKTELQSPEHPLDQHYRNLHCALRPLDHESYEFKVISQYLQSTHAPTHSDYTMTLLDLFEVEKDGEKEAFREDLHNRMLLWHGSRMSNWVGILSHGLRIAPPEAPITGYMFGKGIYFADMSSKSANYCFASRLKNTGLLLLSEVALGQCNELLEANPKAEGLLQGKHSTKGLGKMAPSSAHFVTLNGSTVPLGPASDTGILNPDGYTLNYNEYIVYNPNQVRMRYLLKVQFNFLQLW | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Phosphorylation | MAARRRRSTGGGRAR CCCCCCCCCCCHHHH | 29.59 | 23882029 | |
| 9 | Phosphorylation | AARRRRSTGGGRARA CCCCCCCCCCHHHHH | 37.73 | 23882029 | |
| 20 | Phosphorylation | RARALNESKRVNNGN HHHHCCCCCCCCCCC | 25.37 | 23882029 | |
| 28 | Phosphorylation | KRVNNGNTAPEDSSP CCCCCCCCCCCCCCH | 45.01 | 23403867 | |
| 33 | Phosphorylation | GNTAPEDSSPAKKTR CCCCCCCCCHHHHHH | 36.24 | 23401153 | |
| 33 (in isoform 2) | Phosphorylation | - | 36.24 | - | |
| 34 | Phosphorylation | NTAPEDSSPAKKTRR CCCCCCCCHHHHHHH | 40.99 | 23401153 | |
| 34 (in isoform 2) | Phosphorylation | - | 40.99 | - | |
| 37 | Acetylation | PEDSSPAKKTRRCQR CCCCCHHHHHHHHHH | 59.05 | 18436469 | |
| 38 | Acetylation | EDSSPAKKTRRCQRQ CCCCHHHHHHHHHHH | 49.74 | 18436469 | |
| 39 | Phosphorylation | DSSPAKKTRRCQRQE CCCHHHHHHHHHHHH | 23.73 | 28111955 | |
| 47 | Phosphorylation | RRCQRQESKKMPVAG HHHHHHHHCCCCCCC | 29.28 | 24719451 | |
| 71 | Ubiquitination | DKQDGMPGRSWASKR CCCCCCCCCHHHHHH | 27.62 | 29967540 | |
| 82 | Phosphorylation | ASKRVSESVKALLLK HHHHHHHHHHHHHHC | 22.78 | 33259812 | |
| 88 | Ubiquitination | ESVKALLLKGKAPVD HHHHHHHHCCCCCCC | 7.75 | 29967540 | |
| 91 | Ubiquitination | KALLLKGKAPVDPEC HHHHHCCCCCCCHHH | 48.18 | 33845483 | |
| 101 | Ubiquitination | VDPECTAKVGKAHVY CCHHHCCEECCEEEE | 33.11 | 29967540 | |
| 104 | Ubiquitination | ECTAKVGKAHVYCEG HHCCEECCEEEEECC | 38.00 | 29967540 | |
| 115 | Phosphorylation | YCEGNDVYDVMLNQT EECCCCHHEEEECCE | 12.99 | - | |
| 158 | Ubiquitination | WGRVGKMGQHSLVAC ECCCCCCCCCCEEEE | 26.07 | 29967540 | |
| 160 | Ubiquitination | RVGKMGQHSLVACSG CCCCCCCCCEEEECC | 19.85 | 29967540 | |
| 171 | Ubiquitination | ACSGNLNKAKEIFQK EECCCHHHHHHHHHH | 65.09 | 29967540 | |
| 173 | Ubiquitination | SGNLNKAKEIFQKKF CCCHHHHHHHHHHHH | 53.61 | 29967540 | |
| 183 | Ubiquitination | FQKKFLDKTKNNWED HHHHHHHHHCCCHHH | 64.64 | 29967540 | |
| 196 | Ubiquitination | EDREKFEKVPGKYDM HHHHHHHCCCCCCCE | 57.79 | 29967540 | |
| 201 | Phosphorylation | FEKVPGKYDMLQMDY HHCCCCCCCEEECCC | 16.70 | 22468782 | |
| 208 | Phosphorylation | YDMLQMDYATNTQDE CCEEECCCCCCCCCH | 15.24 | 26552605 | |
| 210 | Phosphorylation | MLQMDYATNTQDEEE EEECCCCCCCCCHHH | 32.35 | 26552605 | |
| 212 | Phosphorylation | QMDYATNTQDEEETK ECCCCCCCCCHHHHH | 32.80 | 26552605 | |
| 212 | Ubiquitination | QMDYATNTQDEEETK ECCCCCCCCCHHHHH | 32.80 | 29967540 | |
| 216 | Ubiquitination | ATNTQDEEETKKEES CCCCCCHHHHHHHHH | 78.31 | 33845483 | |
| 218 | Phosphorylation | NTQDEEETKKEESLK CCCCHHHHHHHHHHC | 51.17 | 22468782 | |
| 223 | Phosphorylation | EETKKEESLKSPLKP HHHHHHHHHCCCCCC | 42.04 | 25850435 | |
| 225 | Ubiquitination | TKKEESLKSPLKPES HHHHHHHCCCCCCHH | 60.34 | 29967540 | |
| 226 | Phosphorylation | KKEESLKSPLKPESQ HHHHHHCCCCCCHHH | 40.53 | 25159151 | |
| 229 | Ubiquitination | ESLKSPLKPESQLDL HHHCCCCCCHHHHHH | 50.55 | 33845483 | |
| 232 | Phosphorylation | KSPLKPESQLDLRVQ CCCCCCHHHHHHHHH | 44.57 | 21406692 | |
| 256 | Ubiquitination | QAMEEMMMEMKYNTK HHHHHHHHHHCCCCC | 4.37 | 29967540 | |
| 260 | Phosphorylation | EMMMEMKYNTKKAPL HHHHHHCCCCCCCCC | 27.10 | 23663014 | |
| 262 | Phosphorylation | MMEMKYNTKKAPLGK HHHHCCCCCCCCCCC | 30.72 | 23663014 | |
| 263 | Ubiquitination | MEMKYNTKKAPLGKL HHHCCCCCCCCCCCE | 43.21 | 21890473 | |
| 263 (in isoform 2) | Ubiquitination | - | 43.21 | 21890473 | |
| 269 | Ubiquitination | TKKAPLGKLTVAQIK CCCCCCCCEEHHHHH | 48.98 | 29967540 | |
| 271 | Phosphorylation | KAPLGKLTVAQIKAG CCCCCCEEHHHHHHH | 19.79 | 21406692 | |
| 276 | Ubiquitination | KLTVAQIKAGYQSLK CEEHHHHHHHHHHHH | 24.55 | 22817900 | |
| 276 (in isoform 1) | Ubiquitination | - | 24.55 | 21890473 | |
| 279 | Phosphorylation | VAQIKAGYQSLKKIE HHHHHHHHHHHHHHH | 10.37 | 28796482 | |
| 317 | Phosphorylation | PHDFGLRTPPLIRTQ CCCCCCCCCCCCCCH | 34.01 | 24719451 | |
| 328 | Phosphorylation | IRTQKELSEKIQLLE CCCHHHHHHHHHHHH | 37.62 | 24719451 | |
| 332 | Ubiquitination | KELSEKIQLLEALGD HHHHHHHHHHHHHCC | 51.57 | 22817900 | |
| 335 (in isoform 2) | Ubiquitination | - | 50.90 | 21890473 | |
| 335 | Ubiquitination | SEKIQLLEALGDIEI HHHHHHHHHHCCHHH | 50.90 | 21890473 | |
| 345 | Ubiquitination | GDIEIAIKLVKTELQ CCHHHHHHHHHHHHC | 37.90 | 22817900 | |
| 348 (in isoform 1) | Ubiquitination | - | 46.87 | 21890473 | |
| 348 | Ubiquitination | EIAIKLVKTELQSPE HHHHHHHHHHHCCCC | 46.87 | 22817900 | |
| 353 | Phosphorylation | LVKTELQSPEHPLDQ HHHHHHCCCCCCCHH | 44.90 | 25159151 | |
| 383 | Phosphorylation | SYEFKVISQYLQSTH CHHHHHHHHHHHHCC | 18.76 | - | |
| 389 | Phosphorylation | ISQYLQSTHAPTHSD HHHHHHHCCCCCCCC | 14.75 | - | |
| 430 | Phosphorylation | RMLLWHGSRMSNWVG HHHHHCHHHHHHHHH | 16.36 | 20068231 | |
| 456 | Ubiquitination | EAPITGYMFGKGIYF CCCCCEEECCCCEEE | 3.65 | 32015554 | |
| 467 | Phosphorylation | GIYFADMSSKSANYC CEEEEECCCCCCCCC | 34.85 | - | |
| 469 | Ubiquitination | YFADMSSKSANYCFA EEEECCCCCCCCCHH | 46.40 | 32015554 | |
| 473 | Phosphorylation | MSSKSANYCFASRLK CCCCCCCCCHHHHCH | 6.67 | 28152594 | |
| 480 | Ubiquitination | YCFASRLKNTGLLLL CCHHHHCHHHCCHHH | 51.89 | - | |
| 499 | Ubiquitination | LGQCNELLEANPKAE HHHHHHHHHHCCCCC | 4.81 | 29967540 | |
| 512 | Ubiquitination | AEGLLQGKHSTKGLG CCCCCCCCCCCCCCC | 22.78 | 29967540 | |
| 514 | Phosphorylation | GLLQGKHSTKGLGKM CCCCCCCCCCCCCCC | 34.99 | 22964224 | |
| 516 | Ubiquitination | LQGKHSTKGLGKMAP CCCCCCCCCCCCCCC | 55.97 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PARP2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PARP2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PARP2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| XRCC1_HUMAN | XRCC1 | physical | 11948190 | |
| STP2_HUMAN | TNP2 | physical | 19607827 | |
| HSP72_HUMAN | HSPA2 | physical | 19607827 | |
| TIF1B_HUMAN | TRIM28 | physical | 18676401 | |
| CBX5_HUMAN | CBX5 | physical | 18676401 | |
| NPM_MOUSE | Npm1 | physical | 15615785 | |
| UHRF1_HUMAN | UHRF1 | physical | 24782312 | |
| HPF1_HUMAN | C4orf27 | physical | 27067600 | |
| H31T_HUMAN | HIST3H3 | physical | 28190768 | |
| H15_HUMAN | HIST1H1B | physical | 28190768 | |
| H31_HUMAN | HIST1H3A | physical | 28190768 | |
| H33_HUMAN | H3F3A | physical | 28190768 | |
| H10_HUMAN | H1F0 | physical | 28190768 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...